Insulin resistance more severe in patients with primary hyperparathyroidism: study

In a cross-sectional study of consecutive primary hyperparathyroidism patients without a history of diabetes or severe chronic kidney disease Fasting, glucose and insulin were evaluated before parathyroidectomy. Glucose metabolism was compared with population-based control subjects

The results of the study are:

• One hundred and seventy-four patients with primary hyperparathyroidism (140 females) were included.
• Mean fasting glucose was 0.983 ± 0.129 g/L, and 63 patients (36%) had prediabetes (>1.0 g/L).
• The mean Homeostatic model assessment of insulin resistance (HOMA-IR) was 3.386 ± 3.111 mUI/L, and 78 patients (45%) had insulin resistance
• Blood calcium levels and body mass index were correlated positively with HOMA-IR.
• Insulin secretion was correlated positively with preoperative systolic blood pressure in mm Hg
• In multivariate analysis, classic hypercalcemic primary hyperparathyroidism, mild hypercalcemic primary hyperparathyroidism and body mass index remained independent predictors for insulin resistance
• When compared with control subjects, mean HOMA-IR was significantly higher in primary hyperparathyroidism patients

Thus, insulin resistance was significantly higher in primary hyperparathyroidism patients than in control subjects. The impact of parathyroidectomy on insulin resistance should be evaluated in patients with higher calcium levels

Reference:

Ashwaq Al-Jehani, Feras Al-Ahmed, Phi-Linh Nguyen-Thi, Florence Bihain, Claire Nomine-Criqui, Lea Demarquet, Bruno Guerci, Olivier Ziegler, Laurent Brunaud, Insulin resistance is more severe in patients with primary hyperparathyroidism, Surgery, Volume 172, Issue 2, 2022, Pages 552-558, ISSN 0039-6060, https://doi.org/10.1016/j.surg.2022.02.012.